UVSP Q1 2026 Earnings EPS Surges 15 Above Estimates on Strong Core Operations XPEL Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Gain Ground InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines TSHA Q1 2026 Earnings WiderthanExpected Loss as Company Continues Development Pipeline QUAD Q1 2026 Earnings EPS Beat Underpins Cost Discipline Stock Edges Higher WRB Q1 2026 Earnings Strong Underwriting and Investment Performance Drive 124 EPS Beat